{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:34:26Z","timestamp":1792690466646,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00134-020-05945-3","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T07:02:33Z","timestamp":1580713353000},"page":"329-342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Management of HIV-infected patients in the intensive care unit"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-7265","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Barbier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervin","family":"Mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Szychowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Mariotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Galicier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Bouadma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"5945_CR1","unstructured":"World Health Organization (2019) Global HIV and AIDS statistics. http:\/\/www.unaids.org. Accessed 1 Nov 2019"},{"issue":"2","key":"5945_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0036-1572561","volume":"37","author":"KM Akgun","year":"2016","unstructured":"Akgun KM, Miller RF (2016) Critical care in human immunodeficiency virus-infected patients. Semin Respir Crit Care Med 37(2):303\u2013317","journal-title":"Semin Respir Crit Care Med"},{"key":"5945_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.08.002","author":"E Azoulay","year":"2019","unstructured":"Azoulay E, de Castro N, Barbier F (2019) Critically ill patients with HIV: 40 years later. Chest. https:\/\/doi.org\/10.1016\/j.chest.2019.08.002","journal-title":"Chest"},{"issue":"1","key":"5945_CR4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/QAI.0b013e318278f3fa","volume":"62","author":"KM Akgun","year":"2013","unstructured":"Akgun KM, Gordon K, Pisani M, Fried T, McGinnis KA, Tate JP et al (2013) Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr 62(1):52\u201359","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"5945_CR5","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/cc9056","volume":"14","author":"I Coquet","year":"2010","unstructured":"Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J et al (2010) Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 14(3):R107","journal-title":"Crit Care"},{"issue":"4","key":"5945_CR6","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/cc9221","volume":"14","author":"AM Japiassu","year":"2010","unstructured":"Japiassu AM, Amancio RT, Mesquita EC, Medeiros DM, Bernal HB, Nunes EP et al (2010) Sepsis is a major determinant of outcome in critically ill HIV\/AIDS patients. Crit Care 14(4):R152","journal-title":"Crit Care"},{"issue":"4","key":"5945_CR7","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/cc10419","volume":"15","author":"HH Chiang","year":"2011","unstructured":"Chiang HH, Hung CC, Lee CM, Chen HY, Chen MY, Sheng WH et al (2011) Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care 15(4):R202","journal-title":"Crit Care"},{"issue":"3","key":"5945_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jmv.24063","volume":"87","author":"J Xiao","year":"2015","unstructured":"Xiao J, Zhang W, Huang Y, Tian Y, Su W, Li Y et al (2015) Etiology and outcomes for patients infected with HIV in intensive care units in a tertiary care hospital in China. J Med Virol 87(3):366\u2013374","journal-title":"J Med Virol"},{"key":"5945_CR9","first-page":"2610873","volume":"2016","author":"A Kwizera","year":"2016","unstructured":"Kwizera A, Nabukenya M, Peter A, Semogerere L, Ayebale E, Katabira C et al (2016) Clinical characteristics and short-term outcomes of HIV patients admitted to an african intensive care unit. Crit Care Res Pract 2016:2610873","journal-title":"Crit Care Res Pract"},{"issue":"9903","key":"5945_CR10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV (2013) The end of AIDS: HIV infection as a chronic disease. Lancet 382(9903):1525\u20131533","journal-title":"Lancet"},{"key":"5945_CR11","unstructured":"World Health Organization (2016) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2nd edn. https:\/\/www.who.int. Accessed 1 Nov 2019"},{"key":"5945_CR12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/cid\/ciu869","volume":"60","author":"KN Althoff","year":"2014","unstructured":"Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK et al (2014) Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected vs uninfected adults. Clin Infect Dis 60:627\u2013638","journal-title":"Clin Infect Dis"},{"key":"5945_CR13","first-page":"1","volume":"2013","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL et al (2013) HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013:1\u20139","journal-title":"JAMA Intern Med"},{"issue":"2","key":"5945_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ijc.25903","volume":"129","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Spano JP, Bonnet F, Guiguet M, Boue F, Cadranel J et al (2011) The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer 129(2):467\u2013475","journal-title":"Int J Cancer"},{"issue":"3","key":"5945_CR15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.201006-0836OC","volume":"183","author":"K Crothers","year":"2011","unstructured":"Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC et al (2011) HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 183(3):388\u2013395","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"5945_CR16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","volume":"26","author":"K Sigel","year":"2012","unstructured":"Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST et al (2012) HIV as an independent risk factor for incident lung cancer. AIDS 26(8):1017\u20131025","journal-title":"AIDS"},{"issue":"11","key":"5945_CR17","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/cid\/cit497","volume":"57","author":"M Hleyhel","year":"2013","unstructured":"Hleyhel M, Belot A, Bouvier A-M, Tattevin P, Pacanowski J, Genet P et al (2013) Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS C04 Cohort. Clin Infect Dis 57(11):1638\u20131647","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5945_CR18","doi-asserted-by":"crossref","first-page":"e0176686","DOI":"10.1371\/journal.pone.0176686","volume":"12","author":"J Gutierrez","year":"2017","unstructured":"Gutierrez J, Albuquerque ALA, Falzon L (2017) HIV infection as vascular risk: a systematic review of the literature and meta-analysis. PLoS One 12(5):e0176686","journal-title":"PLoS One"},{"issue":"1","key":"5945_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001554","volume":"77","author":"BB Hart","year":"2018","unstructured":"Hart BB, Nordell AD, Okulicz JF, Palfreeman A, Horban A, Kedem E et al (2018) Inflammation-related morbidity and mortality among HIV-positive adults: how extensive is it? J Acquir Immune Defic Syndr 77(1):1\u20137","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"5945_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QCO.0000000000000341","volume":"30","author":"DB Gootenberg","year":"2017","unstructured":"Gootenberg DB, Paer JM, Luevano JM, Kwon DS (2017) HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation. Curr Opin Infect Dis 30(1):31\u201343","journal-title":"Curr Opin Infect Dis"},{"key":"5945_CR21","doi-asserted-by":"crossref","first-page":"847835","DOI":"10.1155\/2011\/847835","volume":"2011","author":"L Turtle","year":"2011","unstructured":"Turtle L, Vyakernam R, Menon-Johansson A, Nelson MR, Soni N (2011) Intensive care usage by HIV-positive patients in the HAART Era. Interdiscip Perspect Infect Dis 2011:847835","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"9","key":"5945_CR22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10096-011-1196-z","volume":"30","author":"SF van Lelyveld","year":"2011","unstructured":"van Lelyveld SF, Wind CM, Mudrikova T, van Leeuwen HJ, de Lange DW, Hoepelman AI (2011) Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis 30(9):1085\u20131093","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"5945_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2110-5820-2-25","volume":"2","author":"D Morquin","year":"2012","unstructured":"Morquin D, Le Moing V, Mura T, Makinson A, Klouche K, Jonquet O et al (2012) Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care 2(1):25","journal-title":"Ann Intensive Care"},{"issue":"6","key":"5945_CR24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/CCM.0b013e31827caa46","volume":"41","author":"KM Akgun","year":"2013","unstructured":"Akgun KM, Tate JP, Pisani M, Fried T, Butt AA, Gibert CL et al (2013) Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med 41(6):1458\u20131467","journal-title":"Crit Care Med"},{"key":"5945_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11904-019-00460-7","volume":"16","author":"J Botha","year":"2019","unstructured":"Botha J, Fabian J, Etheredge H, Conradie F, Tiemessen CT (2019) HIV and solid organ transplantation: where are we now. Curr HIV AIDS Rep 16:404\u2013413","journal-title":"Curr HIV AIDS Rep"},{"key":"5945_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15257","author":"S Madan","year":"2019","unstructured":"Madan S, Patel SR, Saeed O, Sims DB, Shin JJ, Goldstein DJ et al (2019) Outcomes of heart transplantation in patients with human immunodeficiency virus. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.15257","journal-title":"Am J Transplant."},{"issue":"6","key":"5945_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MNH.0000000000000071","volume":"23","author":"D Sawinski","year":"2014","unstructured":"Sawinski D, Bloom RD (2014) Current status of kidney transplantation in HIV-infected patients. Curr Opin Nephrol Hypertens 23(6):619\u2013624","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"5945_CR28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0956462417693734","volume":"28","author":"EJ Lee","year":"2017","unstructured":"Lee EJ, Kim YH, Lee JY, Sunwoo JS, Park SY, Kim TH (2017) Acute HIV-1 infection presenting with fulminant encephalopathy. Int J STD AIDS 28(10):1041\u20131044","journal-title":"Int J STD AIDS"},{"issue":"3","key":"5945_CR29","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1086\/510683","volume":"44","author":"P Tattevin","year":"2007","unstructured":"Tattevin P, Camus C, Arvieux C, Ruffault A, Michelet C (2007) Multiple organ failure during primary HIV infection. Clin Infect Dis 44(3):e28\u2013e29","journal-title":"Clin Infect Dis"},{"issue":"11","key":"5945_CR30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0956462414560777","volume":"26","author":"MA Ferrada","year":"2015","unstructured":"Ferrada MA, Xie Y, Nuermberger E (2015) Primary HIV infection presenting as limbic encephalitis and rhabdomyolysis. Int J STD AIDS 26(11):835\u2013836","journal-title":"Int J STD AIDS"},{"issue":"2","key":"5945_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0956462416654852","volume":"28","author":"G Vandi","year":"2017","unstructured":"Vandi G, Calza L, Girometti N, Manfredi R, Musumeci G, Bon I et al (2017) Acute onset myopericarditis as unusual presentation of primary HIV infection. Int J STD AIDS 28(2):199\u2013201","journal-title":"Int J STD AIDS"},{"issue":"11","key":"5945_CR32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/thx.2006.072256","volume":"62","author":"SJ Dickson","year":"2007","unstructured":"Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF (2007) Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 62(11):964\u2013968","journal-title":"Thorax"},{"key":"5945_CR33","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00134-014-3481-7","volume":"40","author":"F Barbier","year":"2014","unstructured":"Barbier F, Roux A, Canet E, Martel-Samb P, Aegerter P, Wolff M et al (2014) Temporal trends in critical events complicating HIV infection: 1999\u20132010 multicentre cohort study in France. Intensive Care Med 40:1906\u20131915","journal-title":"Intensive Care Med"},{"issue":"2","key":"5945_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chest.2017.03.007","volume":"152","author":"C Cilloniz","year":"2017","unstructured":"Cilloniz C, Torres A, Manzardo C, Gabarrus A, Ambrosioni J, Salazar A et al (2017) Community-acquired pneumococcal pneumonia in virologically suppressed HIV-infected adult patients: a matched case-control study. Chest 152(2):295\u2013303","journal-title":"Chest"},{"issue":"6","key":"5945_CR35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/cid\/ciy314","volume":"67","author":"C Cilloniz","year":"2018","unstructured":"Cilloniz C, Miguel-Escuder L, Pedro-Bonet ML, Falco V, Lopez Y, Garcia-Vidal C et al (2018) Community-acquired Legionella pneumonia in Human Immunodeficiency Virus-infected adult patients: a matched case-control study. Clin Infect Dis 67(6):958\u2013961","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5945_CR36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jinf.2016.01.001","volume":"72","author":"KE van Veen","year":"2016","unstructured":"van Veen KE, Brouwer MC, van der Ende A, van de Beek D (2016) Bacterial meningitis in patients with HIV: a population-based prospective study. J Infect 72(3):362\u2013368","journal-title":"J Infect"},{"key":"5945_CR37","doi-asserted-by":"crossref","first-page":"205031211668429","DOI":"10.1177\/2050312116684295","volume":"4","author":"H Imlay","year":"2016","unstructured":"Imlay H, Kaul D, Rao K (2016) Risk factors for Clostridium difficile infection in HIV-infected patients. SAGE Open Med 4:2050312116684295","journal-title":"SAGE Open Med"},{"issue":"11","key":"5945_CR38","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1086\/498027","volume":"41","author":"TH Sanchez","year":"2005","unstructured":"Sanchez TH, Brooks JT, Sullivan PS, Juhasz M, Mintz E, Dworkin MS et al (2005) Bacterial diarrhea in persons with HIV infection, United States, 1992\u20132002. Clin Infect Dis 41(11):1621\u20131627","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5945_CR39","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/CCM.0000000000001003","volume":"43","author":"SK Cribbs","year":"2015","unstructured":"Cribbs SK, Tse C, Andrews J, Shenvi N, Martin GS (2015) Characteristics and outcomes of HIV-infected patients with severe sepsis: continued risk in the post-highly active antiretroviral therapy era. Crit Care Med 43(8):1638\u20131645","journal-title":"Crit Care Med"},{"issue":"2","key":"5945_CR40","doi-asserted-by":"crossref","first-page":"e0148955","DOI":"10.1371\/journal.pone.0148955","volume":"11","author":"MA Huson","year":"2016","unstructured":"Huson MA, Scicluna BP, van Vught LA, Wiewel MA, Hoogendijk AJ, Cremer OL et al (2016) The impact of HIV co-infection on the genomic response to sepsis. PLoS One 11(2):e0148955","journal-title":"PLoS One"},{"issue":"1","key":"5945_CR41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13054-016-1469-0","volume":"20","author":"MA Wiewel","year":"2016","unstructured":"Wiewel MA, Huson MA, van Vught LA, Hoogendijk AJ, Klein Klouwenberg PM, Horn J et al (2016) Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study. Crit Care 20(1):322","journal-title":"Crit Care"},{"issue":"3","key":"5945_CR42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock, 2016. Intensive Care Med 43(3):304\u2013377","journal-title":"Intensive Care Med"},{"issue":"1","key":"5945_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-6405-9-27","volume":"9","author":"A Meybeck","year":"2012","unstructured":"Meybeck A, Lecomte L, Valette M, Van Grunderbeeck N, Boussekey N, Chiche A et al (2012) Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study. AIDS Res Ther 9(1):27","journal-title":"AIDS Res Ther"},{"key":"5945_CR44","doi-asserted-by":"crossref","first-page":"7868954","DOI":"10.1155\/2017\/7868954","volume":"2017","author":"SL Turvey","year":"2017","unstructured":"Turvey SL, Bagshaw SM, Eurich DT, Sligl WI (2017) Epidemiology and outcomes in critically ill patients with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Can J Infect Dis Med Microbiol 2017:7868954","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"5945_CR45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijcard.2015.08.055","volume":"201","author":"N Mongardon","year":"2015","unstructured":"Mongardon N, Geri G, Deye N, Sonneville R, Boissier F, Perbet S et al (2015) Etiologies, clinical features and outcome of cardiac arrest in HIV-infected patients. Int J Cardiol 201:302\u2013307","journal-title":"Int J Cardiol"},{"issue":"7","key":"5945_CR46","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/CCM.0b013e3181e2a44b","volume":"38","author":"PA Mendez-Tellez","year":"2010","unstructured":"Mendez-Tellez PA, Damluji A, Ammerman D, Colantuoni E, Fan E, Sevransky JE et al (2010) Human immunodeficiency virus infection and hospital mortality in acute lung injury patients. Crit Care Med 38(7):1530\u20131535","journal-title":"Crit Care Med"},{"key":"5945_CR47","first-page":"956462418805606","volume":"2018","author":"LW Collett","year":"2018","unstructured":"Collett LW, Simpson T, Camporota L, Meadows CI, Ioannou N, Glover G et al (2018) The use of extracorporeal membrane oxygenation in HIV-positive patients with severe respiratory failure: a retrospective observational case series. Int J STD AIDS 2018:956462418805606","journal-title":"Int J STD AIDS"},{"issue":"4","key":"5945_CR48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ams2.364","volume":"5","author":"R Obata","year":"2018","unstructured":"Obata R, Azuma K, Nakamura I, Oda J (2018) Severe acute respiratory distress syndrome in a patient with AIDS successfully treated with veno-venous extracorporeal membrane oxygenation: a case report and literature review. Acute Med Surg 5(4):384\u2013389","journal-title":"Acute Med Surg"},{"issue":"4","key":"5945_CR49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jinf.2011.02.003","volume":"62","author":"R Sonneville","year":"2011","unstructured":"Sonneville R, Ferrand H, Tubach F, Roy C, Bouadma L, Klein IF et al (2011) Neurological complications of HIV infection in critically ill patients: clinical features and outcomes. J Infect 62(4):301\u2013308","journal-title":"J Infect"},{"issue":"4","key":"5945_CR50","first-page":"475","volume":"18","author":"J Medrano","year":"2014","unstructured":"Medrano J, Alvaro-Meca A, Boyer A, Jimenez-Sousa MA, Resino S (2014) Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis. Crit Care 18(4):475","journal-title":"Crit Care"},{"issue":"10","key":"5945_CR51","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s00134-009-1559-4","volume":"35","author":"F Barbier","year":"2009","unstructured":"Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J et al (2009) Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 35(10):1678\u20131686","journal-title":"Intensive Care Med"},{"issue":"6","key":"5945_CR52","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1183\/09031936.00155813","volume":"43","author":"C Cilloniz","year":"2014","unstructured":"Cilloniz C, Torres A, Polverino E, Gabarrus A, Amaro R, Moreno E et al (2014) Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome. Eur Respir J 43(6):1698\u20131708","journal-title":"Eur Respir J"},{"issue":"3","key":"5945_CR53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1513\/pats.201006-044WR","volume":"8","author":"LN Segal","year":"2011","unstructured":"Segal LN, Methe BA, Nolan A, Hoshino Y, Rom WN, Dawson R et al (2011) HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 8(3):282\u2013287","journal-title":"Proc Am Thorac Soc"},{"key":"5945_CR54","unstructured":"The Centers for Disease Control and Prevention tNIoH, the HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. http:\/\/www.aidsinfo.nih.gov. Accessed 1 Nov 2019"},{"issue":"1","key":"5945_CR55","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/S2468-2667(17)30211-6","volume":"3","author":"J Pannetier","year":"2018","unstructured":"Pannetier J, Ravalihasy A, Lydie N, Lert F, du Lou DA (2018) Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Lancet Public Health 3(1):e16\u2013e23","journal-title":"Lancet Public Health"},{"issue":"7","key":"5945_CR56","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/cid\/cis1016","volume":"56","author":"AE McCarthy","year":"2013","unstructured":"McCarthy AE, Weld LH, Barnett ED, So H, Coyle C, Greenaway C et al (2013) Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997\u20132009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin Infect Dis 56(7):925\u2013933","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5945_CR57","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3201\/eid2009.131668","volume":"20","author":"A Roux","year":"2014","unstructured":"Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A et al (2014) Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis 20(9):1490\u20131497","journal-title":"Emerg Infect Dis"},{"key":"5945_CR58","unstructured":"Miller RF, Walzer PD, Smulian AG (2019) Pneumocystis species\u2014Chapter 269 in: Mandell, Douglas and Benett\u2019s Principles and practices of infectious diseases, 9th edn. In: Benett JE, Dolin R, Blaser MJ (eds) Elsiever Science, Amsterdam"},{"issue":"1","key":"5945_CR59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/523814","volume":"197","author":"A Morris","year":"2008","unstructured":"Morris A, Wei K, Afshar K, Huang L (2008) Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 197(1):10\u201317","journal-title":"J Infect Dis"},{"issue":"12","key":"5945_CR60","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/JCM.02072-15","volume":"53","author":"M Louis","year":"2015","unstructured":"Louis M, Guitard J, Jodar M, Ancelle T, Magne D, Lascols O et al (2015) Impact of HIV infection status on interpretation of quantitative PCR for detection of Pneumocystis jirovecii. J Clin Microbiol 53(12):3870\u20133875","journal-title":"J Clin Microbiol"},{"issue":"6","key":"5945_CR61","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JCM.03174-15","volume":"54","author":"T Fauchier","year":"2016","unstructured":"Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C (2016) Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in immunocompromised HIV-positive and HIV-negative patients. J Clin Microbiol 54(6):1487\u20131495","journal-title":"J Clin Microbiol"},{"issue":"12","key":"5945_CR62","first-page":"2214","volume":"7","author":"WJ Li","year":"2015","unstructured":"Li WJ, Guo YL, Liu TJ, Wang K, Kong JL (2015) Diagnosis of pneumocystis pneumonia using serum (1-3)-beta-D-Glucan: a bivariate meta-analysis and systematic review. J Thorac Dis 7(12):2214\u20132225","journal-title":"J Thorac Dis"},{"issue":"1","key":"5945_CR63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","volume":"50","author":"A Onishi","year":"2012","unstructured":"Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S et al (2012) Diagnostic accuracy of serum 1,3-beta-d-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50(1):7\u201315","journal-title":"J Clin Microbiol"},{"issue":"3","key":"5945_CR64","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.chest.2018.04.026","volume":"154","author":"PM Wieruszewski","year":"2018","unstructured":"Wieruszewski PM, Barreto JN, Frazee E, Daniels CE, Tosh PK, Dierkhising RA et al (2018) Early corticosteroids for Pneumocystis pneumonia in adults without HIV are not associated with better outcome. Chest 154(3):636\u2013644","journal-title":"Chest"},{"key":"5945_CR65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-14-87","volume":"14","author":"V Lemiale","year":"2013","unstructured":"Lemiale V, Debrumetz A, Delannoy A, Alberti C, Azoulay E (2013) Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia. Respir Res 14:87","journal-title":"Respir Res"},{"key":"5945_CR66","first-page":"CD006150","volume":"4","author":"H Ewald","year":"2015","unstructured":"Ewald H, Raatz H, Boscacci R, Furrer H, Bucher HC, Briel M (2015) Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in patients with HIV infection. Cochrane Database Syst Rev 4:CD006150","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"5945_CR67","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5588\/ijtld.13.0901","volume":"18","author":"JP Lanoix","year":"2014","unstructured":"Lanoix JP, Gaudry S, Flicoteaux R, Ruimy R, Wolff M (2014) Tuberculosis in the intensive care unit: a descriptive analysis in a low-burden country. Int J Tuberc Lung Dis 18(5):581\u2013587","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"5945_CR68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","volume":"18","author":"SE Dorman","year":"2018","unstructured":"Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B et al (2018) Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis 18(1):76\u201384","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"5945_CR69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","volume":"13","author":"JA Critchley","year":"2013","unstructured":"Critchley JA, Young F, Orton L, Garner P (2013) Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 13(3):223\u2013237","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"5945_CR70","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/ciw616","volume":"63","author":"JY Yang","year":"2016","unstructured":"Yang JY, Han M, Koh Y, Kim WS, Song JW, Oh YM et al (2016) Effects of corticosteroids on critically ill pulmonary tuberculosis patients with acute respiratory failure: a propensity analysis of mortality. Clin Infect Dis 63(11):1449\u20131455","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5945_CR71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MCC.0000000000000397","volume":"23","author":"R Sonneville","year":"2017","unstructured":"Sonneville R, Magalhaes E, Meyfroidt G (2017) Central nervous system infections in immunocompromised patients. Curr Opin Crit Care 23(2):128\u2013133","journal-title":"Curr Opin Crit Care"},{"issue":"17","key":"5945_CR72","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1212\/WNL.0b013e3182704040","volume":"79","author":"R Sonneville","year":"2012","unstructured":"Sonneville R, Schmidt M, Messika J, Ait Hssain A, da Silva D, Klein IF et al (2012) Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. Neurology 79(17):1762\u20131766","journal-title":"Neurology"},{"issue":"1","key":"5945_CR73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13054-018-2140-8","volume":"22","author":"M Cantier","year":"2018","unstructured":"Cantier M, Morisot A, Guerot E, Megarbane B, Razazi K, Contou D et al (2018) Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study. Crit Care 22(1):210","journal-title":"Crit Care"},{"issue":"2","key":"5945_CR74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","volume":"374","author":"AD Heemskerk","year":"2016","unstructured":"Heemskerk AD, Bang ND, Mai NT, Chau TT, Phu NH, Loc PP et al (2016) Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med 374(2):124\u2013134","journal-title":"N Engl J Med"},{"key":"5945_CR75","first-page":"CD002244","volume":"4","author":"K Prasad","year":"2016","unstructured":"Prasad K, Singh MB, Ryan H (2016) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 4:CD002244","journal-title":"Cochrane Database Syst Rev"},{"issue":"26","key":"5945_CR76","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc1305981","volume":"368","author":"JN Day","year":"2013","unstructured":"Day JN, Chau TT, Lalloo DG (2013) Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 368(26):2522\u20132523","journal-title":"N Engl J Med"},{"issue":"6","key":"5945_CR77","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","volume":"374","author":"J Beardsley","year":"2016","unstructured":"Beardsley J, Wolbers M, Kibengo FM, Ggayi AB, Kamali A, Cuc NT et al (2016) Adjunctive dexamethasone in HIV-associated cryptococcal meningitis. N Engl J Med 374(6):542\u2013554","journal-title":"N Engl J Med"},{"issue":"6","key":"5945_CR78","doi-asserted-by":"crossref","first-page":"e0129550","DOI":"10.1371\/journal.pone.0129550","volume":"10","author":"MA Vandenhende","year":"2015","unstructured":"Vandenhende MA, Roussillon C, Henard S, Morlat P, Oksenhendler E, Aumaitre H et al (2015) Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2000. PLoS One 10(6):e0129550","journal-title":"PLoS One"},{"issue":"2","key":"5945_CR79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QAI.0000000000000946","volume":"72","author":"R Ramaswami","year":"2016","unstructured":"Ramaswami R, Chia G, Dalla Pria A, Pinato DJ, Parker K, Nelson M et al (2016) Evolution of HIV-associated lymphoma over three decades. J Acquir Immune Defic Syndr 72(2):177\u2013183","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"5945_CR80","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/QAD.0b013e328330f62d","volume":"23","author":"L Gerard","year":"2009","unstructured":"Gerard L, Meignin V, Galicier L, Fieschi C, Leturque N, Piketty C et al (2009) Characteristics of non-Hodgkin lymphoma arising in HIV-infected patients with suppressed HIV replication. AIDS 23(17):2301\u20132308","journal-title":"AIDS"},{"issue":"5","key":"5945_CR81","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3109\/10428194.2014.922181","volume":"56","author":"C Algrin","year":"2015","unstructured":"Algrin C, Faguer S, Lemiale V, Lengline E, Boutboul D, Amorim S et al (2015) Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma. Leuk Lymphoma 56(5):1240\u20131245","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"5945_CR82","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/QAD.0b013e328339e55b","volume":"24","author":"L Fardet","year":"2010","unstructured":"Fardet L, Lambotte O, Meynard JL, Kamouh W, Galicier L, Marzac C et al (2010) Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis. AIDS 24(9):1299\u20131306","journal-title":"AIDS"},{"issue":"2","key":"5945_CR83","doi-asserted-by":"crossref","first-page":"e55870","DOI":"10.1371\/journal.pone.0055870","volume":"8","author":"E Canet","year":"2013","unstructured":"Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D et al (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One 8(2):e55870","journal-title":"PLoS One"},{"issue":"1","key":"5945_CR84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bjh.15506","volume":"183","author":"C Bigenwald","year":"2018","unstructured":"Bigenwald C, Fardet L, Coppo P, Meignin V, Lazure T, Fabiani B et al (2018) A comprehensive analysis of lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. Br J Haematol 183(1):68\u201375","journal-title":"Br J Haematol"},{"issue":"11","key":"5945_CR85","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00134-019-05768-x","volume":"45","author":"L Zafrani","year":"2019","unstructured":"Zafrani L, Canet E, Darmon M (2019) Understanding tumor lysis syndrome. Intensive Care Med 45(11):1608\u20131611. https:\/\/doi.org\/10.1007\/s00134-019-05768-x","journal-title":"Intensive Care Med"},{"issue":"19","key":"5945_CR86","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","volume":"122","author":"SK Barta","year":"2013","unstructured":"Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N et al (2013) Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood 122(19):3251\u20133262","journal-title":"Blood"},{"issue":"5","key":"5945_CR87","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00126334-200208150-00003","volume":"30","author":"L Gerard","year":"2002","unstructured":"Gerard L, Galicier L, Maillard A, Boulanger E, Quint L, Matheron S et al (2002) Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 30(5):478\u2013484","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"33","key":"5945_CR88","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","volume":"30","author":"S Montoto","year":"2012","unstructured":"Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A et al (2012) HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol 30(33):4111\u20134116","journal-title":"J Clin Oncol"},{"issue":"10","key":"5945_CR89","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3109\/10428194.2012.543715","volume":"53","author":"C Ferre","year":"2012","unstructured":"Ferre C, de Guzmao BM, Morgades M, Lacoma A, Marcos P, Jimenez-Lorenzo MJ et al (2012) Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit. Leuk Lymphoma 53(10):1966\u20131970","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"5945_CR90","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/annonc\/mdv036","volume":"26","author":"SK Barta","year":"2015","unstructured":"Barta SK, Samuel MS, Xue X, Wang D, Lee JY, Mounier N et al (2015) Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol 26(5):958\u2013966","journal-title":"Ann Oncol"},{"key":"5945_CR91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-030-03502-0_3","volume":"177","author":"DP Dittmer","year":"2019","unstructured":"Dittmer DP, Damania B (2019) Kaposi\u2019s sarcoma-associated herpesvirus (KSHV)-associated disease in the AIDS patient: an update. Cancer Treat Res 177:63\u201380","journal-title":"Cancer Treat Res"},{"issue":"22","key":"5945_CR92","first-page":"2145","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS (2018) HIV-associated cancers and related diseases. N Engl J Med 378(22):2145","journal-title":"N Engl J Med"},{"issue":"2","key":"5945_CR93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15019","volume":"180","author":"E Oksenhendler","year":"2018","unstructured":"Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M et al (2018) The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol 180(2):206\u2013216","journal-title":"Br J Haematol"},{"issue":"6","key":"5945_CR94","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069.h8002069_2069_2073","volume":"96","author":"E Oksenhendler","year":"2000","unstructured":"Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP et al (2000) High levels of HHV8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96(6):2069\u20132073","journal-title":"Blood"},{"issue":"10","key":"5945_CR95","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2011-08-376012","volume":"119","author":"L Gerard","year":"2012","unstructured":"Gerard L, Michot JM, Burcheri S, Fieschi C, Longuet P, Delcey V et al (2012) Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. Blood 119(10):2228\u20132233","journal-title":"Blood"},{"issue":"6","key":"5945_CR96","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14787210.2015.1029917","volume":"13","author":"C Manzardo","year":"2015","unstructured":"Manzardo C, Guardo AC, Letang E, Plana M, Gatell JM, Miro JM (2015) Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Rev Anti Infect Ther 13(6):751\u2013767","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"5945_CR97","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","volume":"10","author":"M Muller","year":"2010","unstructured":"Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10(4):251\u2013261","journal-title":"Lancet Infect Dis"},{"key":"5945_CR98","unstructured":"The Centers for Disease Control and Prevention, the National Institutes of Health, America atIDSo. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. http:\/\/www.aidsinfo.nih.gov. Accessed 1 Nov 2019"},{"issue":"10","key":"5945_CR99","doi-asserted-by":"crossref","first-page":"e0186968","DOI":"10.1371\/journal.pone.0186968","volume":"12","author":"HB Andrade","year":"2017","unstructured":"Andrade HB, Shinotsuka CR, da Silva IRF, Donini CS, Yeh Li H, de Carvalho FB et al (2017) Highly active antiretroviral therapy for critically ill HIV patients: a systematic review and meta-analysis. PLoS One 12(10):e0186968","journal-title":"PLoS One"},{"issue":"8","key":"5945_CR100","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","volume":"28","author":"MT May","year":"2014","unstructured":"May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S et al (2014) Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 28(8):1193\u20131202","journal-title":"AIDS"},{"issue":"8","key":"5945_CR101","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"The Antiretroviral Therapy Cohort Collaboration","year":"2017","unstructured":"The Antiretroviral Therapy Cohort Collaboration (2017) Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 4(8):e349\u2013e356","journal-title":"Lancet HIV"},{"issue":"3","key":"5945_CR102","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/S2214-109X(14)70364-X","volume":"3","author":"S Nsanzimana","year":"2015","unstructured":"Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N et al (2015) Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health 3(3):e169\u2013e177","journal-title":"Lancet Glob Health"},{"issue":"3","key":"5945_CR103","doi-asserted-by":"crossref","first-page":"e001319","DOI":"10.1136\/bmjgh-2018-001319","volume":"4","author":"DN Bhatta","year":"2019","unstructured":"Bhatta DN, Adhikari R, Karki S, Koirala AK, Wasti SP (2019) Life expectancy and disparities in survival among HIV-infected people receiving antiretroviral therapy: an observational cohort study in Kathmandu, Nepal. BMJ Glob Health 4(3):e001319","journal-title":"BMJ Glob Health"},{"issue":"1","key":"5945_CR104","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4102\/sajhivmed.v18i1.776","volume":"18","author":"G Meintjes","year":"2017","unstructured":"Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C et al (2017) Adult antiretroviral therapy guidelines 2017. S Afr J HIV Med 18(1):776","journal-title":"S Afr J HIV Med"},{"issue":"2","key":"5945_CR105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40121-018-0201-6","volume":"7","author":"A Chawla","year":"2018","unstructured":"Chawla A, Wang C, Patton C, Murray M, Punekar Y, de Ruiter A et al (2018) A review of long-term toxicity of antiretroviral treatment regimens and implications for an aging population. Infect Dis Ther 7(2):183\u2013195","journal-title":"Infect Dis Ther"},{"key":"5945_CR106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2369-14-32","volume":"14","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Melo MJ, Raimundo M, Fragoso A, Antunes F (2013) Long-term risk of mortality for acute kidney injury in HIV-infected patients: a cohort analysis. BMC Nephrol 14:32","journal-title":"BMC Nephrol"},{"issue":"9","key":"5945_CR107","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","volume":"381","author":"WDF Venter","year":"2019","unstructured":"Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M et al (2019) Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med 381(9):803\u2013815","journal-title":"N Engl J Med"},{"issue":"4","key":"5945_CR108","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","volume":"18","author":"S Teeraananchai","year":"2017","unstructured":"Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG (2017) Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med 18(4):256\u2013266","journal-title":"HIV Med"},{"issue":"6","key":"5945_CR109","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/CCM.0b013e31828044d2","volume":"41","author":"N Crum-Cianflone","year":"2013","unstructured":"Crum-Cianflone N (2013) Critical crossroads in the care of human immunodeficiency virus-infected persons*. Crit Care Med 41(6):1579\u20131580","journal-title":"Crit Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-05945-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-020-05945-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-05945-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T02:24:45Z","timestamp":1612232685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-020-05945-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5945"],"URL":"https:\/\/doi.org\/10.1007\/s00134-020-05945-3","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"FB: MSD (advisory board, lecture fees, and conference invitation), BioM\u00e9rieux (lecture fees) and Pfizer (conference invitation). RFM: Gilead (lecture fees and conference invitation). EM: Sanofi (lecture fees). PT: Gilead, Astellas, Coreviome, MSD, Mylan, and Pfizer (consulting fees) and Astellas, BioM\u00e9rieux, Gilead, Pfizer, and MSD (congress or research activities). EA: Gilead, Pfizer, Baxter and Alexion (lecture fees), and Ablynx, Fisher & Payckle, Jazz Pharma, and MSD (financial support for his research group). Other authors have no potential conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}